©2025 Stanford Medicine
NOVOCART®3D for Treatment of Articular Cartilage of the Knee
Not Recruiting
Trial ID: NCT01957722
Purpose
This study is to compare NOVOCART 3D relative to Microfracture for the treatment of knee cartilage defects. Efficacy will be evaluated by both pain and function. Safety will also be evaluated.
Official Title
A Phase 3, Prospective, Randomized, Partially Blinded Multi-Center Study to Measure the Safety and Efficacy of NOVOCART 3D Compared ot Microfracture in the Treatment of Articular Cartilage Defects
Stanford Investigator(s)
Seth Sherman
Associate Professor of Orthopaedic Surgery
Eligibility
Inclusion Criteria:
* Greater than 18 years old
* Isolated articular cartilage lesions on the femoral condyle 2-6 cm2
* Minimum score on the KOOS questionnaire
Exclusion Criteria:
* Instability of the knee joint
* Arthritis
* Autoimmune disease
* Immune suppression
* Prior surgical treatment using mosaicplasty, autologous chondrocyte implantation and/or microfracture (debridement and lavage are acceptable beyond three months from baseline)
* Bone disease
* Any degenerative muscular, connective tissue or neurological condition or other disease process that would interfere with healing or the evaluation of outcome measures.
Intervention(s):
procedure: Microfracture
biological: NOVOCART 3D
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Stanford Medicine
Redwood,
California
94063